Clinical effectiveness of a Malaysian-manufactured CAPD product: A randomised trial.
Mak WY, Leong CT, Ong LM, Bavanandan S, Mushahar L, Goh BL, Wong HS, Ahmad G, Liew YF, Ching CH, Liu WJ, Rahmat K, Tan CH, Ahmad MK, Hassan WHHW, Chan FS, Harun Z, Loh CL, Teng KS, Tye YL, Khan SSF, Koh KH, Abdullah R, Hooi LS.
Mak WY, et al.
Perit Dial Int. 2021 May;41(3):273-283. doi: 10.1177/0896860821993954. Epub 2021 Mar 18.
Perit Dial Int. 2021.
PMID: 33733911
Clinical Trial.
Non-inferiority between two groups was established as no significant difference was found in peritonitis rate (incident rate ratio: 0.91, 95% CI: 0.65-1.28). No significant difference was detected in weekly Kt/V (p = 0.58) and creatinine clearance (p = 0.55). However, the …
Non-inferiority between two groups was established as no significant difference was found in peritonitis rate (incident rate ratio: 0.91, 95 …